• Bookmarks
    • Add bookmark
  • Login
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact
Close
  • About Us
  • Investigators
    • Dra. Ibane Abasolo Olaortua
    • Dr. Diego Arango del Corro
    • Dra. Gemma Ariceta Iraola
    • Dra. Eva Baldrich Rubio
    • Dra. Coro Bescós Atin
    • Dr. Joan Castell Conesa
    • Dra. Mari Carmen Domínguez Luengo
    • Dr. Manuel Galiñanes Hernández
    • Dr. José Raúl Herance
    • Dr. Joan López Hellín
    • Dr. Mario Marotta Baleriola
    • Dr. Vicenç Martínez Ibáñez
    • Dra. Anna Meseguer Navarro
    • Dr. Victor Puntes
    • Dr. Joan Sayós Ortega
    • Dr. Simó Schwartz Jr
  • Research Groups
    • Biomedical Research in Digestive Tumors
    • Drug Delivery and Targeting
    • Immune Regulation and Immunotherapy Group
    • Kidney Physiopathology
    • Diagnostic Nanotools for Fast Assay and Biosensor Development.
    • New Technologies and Craniofacial Microsurgery
    • Pharmacokinetic Nanoparticles
    • Reparative Therapy of the Heart
    • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
    • Medical Molecular Imaging
  • Preclinical Services
    • In Vitro Experimental Platform
    • In Vivo Experimental Platform
    • Rates & Services
    • Mission, Vision and Quality Policy Statement of FVPR
    • Other services
  • Publications
  • Highlights
  • Contact

All Posts

HomeBlogAll Posts

Thermo-Responsive Hydrogels for Cancer Local Therapy: Challenges and State-of-Art.

28 July, 2021 631

Rafael D, Merce Roca Melendres, Andrade F, Montero S, Martinez-Trucharte F, Vilar-Hernandez M, Francisco Duran-Lara, Schwartz S Jr, Abasolo I Int J Pharm. 2021 Jul 28:120954. doi: 10.1016/j.ijpharm.2021.120954...

Read more

Pluronic F127-micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancer

23 June, 2021 407

Marwa M Abu-Serie, Fernanda Andrade, Patrícia Camára-Sánchez, Joaquin Seras-Franzoso, Diana Rafael, Zamira V Diaz-Riascos, Petra Gener, Ibane Abasolo, Simó Schwartz Jr. Nanomedicine (Lond.) (Epub ahead of print)...

Read more

Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice

13 May, 2021 330

Sandra Claveau , Marek Kindermann , Alexandre Papine , Zamira V Díaz-Riascos,  Xavier Délen, Patrick Georges , Roser López-Alemany , Òscar Martínez Tirado , Jean-Rémi Bertrand , Ibane Abasolo , Petr Cigler , François Treussart Nanoscale.  2021...

Read more

Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method

20 March, 2021 506

  Josep Merlo-Mas, Judit Tomsen Melero, Jose Luis Corchero, Elisabet González Mira, Albert Font, Jannik N.Pedersen, Natalia Garcia Aranda, Edgar Cristóbal-Lecina, Marta Alcaina-Hernando,  Rosa Mendoza, Elena García Fruitós, Teresa...

Read more

Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders

12 March, 2021 377

Seras-Franzoso J, Diaz-Riascos ZV, Corchero JL, Gonzalez P, Garcia-Aranda N, Mandana M, Riera R, Boullosa A, Mancilla S, Grayston A, Molto-Abad M, Garcia-Fruitos E, Mendoza R, Pintos-Morell G, Albertazzi L, Rosell A, Casas J, Villaverde A...

Read more

Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways

10 March, 2021 378

Eva Espinosa-Cano, Miguel Huerta-Madroñala, Patricia Cámara-Sánchez, Joaquin Seras-Franzoso, Simo Schwartz, Ibane Abasolo, Julio San Román, Maria Rosa Aguilar Materials Science & Engineering C.  Available online 10 March 2021, 112024  ...

Read more

Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field

9 March, 2021 340

Andrade F, Roca-Melendres MM, Duran-Lara EF, Rafael D, Schwartz S Jr Cancers (Basel). 2021 Mar 9;13(5). pii: cancers13051164. doi: 10.3390/cancers13051164. https://pubmed.ncbi.nlm.nih.gov/33803133/ Abstract Cancer remains as the second leading...

Read more

Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR

4 March, 2021 841
Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR

Dr. Simó Schwartz Jr. has been appointed as the new general director of the Blood and Tissue Bank, replacing Dr. Enric Argelagués, who leaves his position today, March 1, after 17 years in the management (1993 – 2002 and 2013 – 2021)...

Read more

Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer

4 March, 2021 1019
Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer

Nanomedicine has emerged as a potential therapy for pancreatic cancer, a disease with a 5-year survival rate as low as 5%. The international project NoCanTher was launched in 2016 to test the use of magnetic nanoparticles in treating locally...

Read more

A study by Vall d’Hebron suggests a new strategy for the treatment of colorectal cancer

24 February, 2021 407
A study by Vall d’Hebron suggests a new strategy for the treatment of colorectal cancer

The research group on CIBBIM-Nanomedicine, Drug Delivery and Targeting of the Vall d’Hebron Research Institute (VHIR) has recently participated in a study with the aim of finding a useful treatment to combat colorectal cancer, but also to...

Read more

Impact of Chemical Composition on the Nanostructure and Biological Activity of alpha-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment.

24 February, 2021 334

Tomsen-Melero J, Passemard S, Garcia-Aranda N, Diaz-Riascos ZV, Gonzalez-Rioja R, Nedergaard Pedersen , Lyngso J, Merlo-Mas J, Cristobal-Lecina E, Corchero JL, Pulido D, Camara-Sanchez P, Portnaya I, Ionita I, Schwartz S Jr, Veciana J, Sala S...

Read more

Created BSURE Medical, a new spin-off of the VHIR

15 February, 2021 494
Created BSURE Medical, a new spin-off of the VHIR

The creation of BSURE Medical represents the culmination of the valuation and transfer strategy carried out by the VHIR Innovation Unit of a research project of which Dr. Jaume Alijotas Reig and Dr. Simo Schwartz Jr are the main researchers and...

Read more
123…11-2021-21
Search
Categories
  • About-us
  • Biomedical Research in Digestive Tumors
  • Drug Delivery and Targeting
  • events
  • Immune Regulation and Immunotherapy Group
  • Kidney Physiopathology
  • New Technologies and Craniofacial Microsurgery
  • News
  • Pharmacokinetic Nanoparticles
  • Publications
  • The Bioengineering, Cell Therapy and Surgery in Congenital Malformations (Bio-Cell Fetal)
  • Uncategorized
Recent Posts
Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR
Dr. Simó Schwartz Jr. assumes the general direction of the Blood and Tissue Bank after 16 years at VHIR
4 March, 2021by CIBBIM - Nanomedicine0
Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer
Vall d’Hebron leads a clinical study testing the use of nanoparticles for the treatment of locally advanced pancreatic cancer
4 March, 2021by CIBBIM - Nanomedicine0
Tags
CLINICAL APPLICATION OF NANOMEDICINE ESNAM EUROPEAN SOCIETY FOR NANOMEDICINE INTERNATIONAL SOCIETY OF NANOMEDICINE ISN
Contact Us
CIBBIM-Nanomedicine
Institut de Recerca
Hospital Universitari Vall d'Hebron
Passeig Vall d'Hebron, 119-129-
08035 Barcelona - Spain
Tel: +34 93 489 4055
Fax: +34 93 489 4040
  • Email: info@cibbim.eu


CIBBIM-Nanomedicine laboratories are located within VHIR’s premises (Mediterrània and Collserola buildings, in violet), Bus lines and Metro stations (Line Green (L3); stops of Montbau and Vall d’Hebron) are also indicated.

ACCESS MAP LOCAL
Albertino © 2014 All Rights Reserved
Forgot password?
You can login using your social profile
Problem with login?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More